New study shows disability claims for mental disorders in UK have doubled over past 20 years

A new paper by Sebastiao Viola and Joanna Moncrieff in the British Journal of Psychiatry shows that disability claims for mental disorders in the UK rose from 572,000 claims in 1995 to 1,162,000 claims in 2014.  Of the claims in 2014, over 44% were for depressive disorders while 23% were for anxiety and other neurotic disorders.  This […]

Continue Reading 4

Review of CEP conference ‘More Harm than Good’ in latest Human Givens Journal

The new issue of the Human Givens Journal includes a comprehensive review of CEP’s conference last year entitled ‘More Harm than Good: Confronting the Psychiatric Medication Epidemic’. In addition, the journal contains an article which covers the recent BMA report on prescribed drug dependence, for which CEP contributed evidence. Both articles can be downloaded via […]

Continue Reading 1

CEP welcomes report by the BMA on prescribed drug dependence

The Council for Evidence-based Psychiatry welcomes the publication of the analysis report by the BMA’s Board of Science, titled ‘Prescribed drugs associated with dependence and withdrawal – building a consensus for action’, which can be viewed here. The report analyses evidence submissions from a variety of stakeholders, including CEP, patient groups and medical bodies such as the […]

Continue Reading 1

Short videos of talks from psychiatric drug harm conference now available

CEP has now published individual videos of each to the talks given at the recent conference ‘More Harm than Good’ on psychiatric drug harm.  These have been professionally edited, with improved sound and multiple camera angles. They can be seen on our YouTube channel at: https://www.youtube.com/channel/UC8eIK8kuf7tht1gV1HApH0g. The individual talks are: Dr James Davies: The Origins of […]

Continue Reading 4

Fluoxetine / sertraline / mirtazapine / citalopram: new withdrawal survey

PLEASE NOTE THAT THIS SURVEY IS NOW CLOSED – THANK YOU FOR YOU HELP! CEP is pleased to support a new research project undertaken by a prominent UK university which will assess the impact of withdrawal from four common antidepressants: fluoxetine (Prozac), sertraline (Zoloft, Lustral), mirtazapine (Remeron, Zispin) and citalopam (Cipramil, Celexa). The researchers have […]

Continue Reading 13

Video and slides now available from ‘More Harm than Good’ conference on psychiatric drug harm

Global leaders in the critical psychiatry movement met on 18 Sep 2015 for a one-day conference to address an urgent public health issue: the iatrogenic harm caused by the over-prescription of psychiatric medications.  The event was recorded and can be viewed on our YouTube channel at https://www.youtube.com/channel/UC8eIK8kuf7tht1gV1HApH0g. We are also editing the talks into shorter videos […]

Continue Reading 1

Daily Mail: ‘Psychiatric drugs… third major killer after heart disease and cancer,’ says Prof Peter Gøtzsche

The Daily Mail today publishes two articles describing the devastating and often deadly impact of psychiatric drugs.  In the first piece, Cochrane Collaboration co-founder Prof Peter Gøtzsche details the findings of his new book, Deadly Psychiatry and Organised Denial (2105). “More than 80 million prescriptions for psychiatric drugs are written in the UK every year,” says Gøtzsche. […]

Continue Reading 4

‘More Harm than Good’ conference can be watched live

CEP is pleased to announce that its upcoming conference More Harm than Good: Confronting the Psychiatric Medication Epidemic will be ‘live streamed’ via YouTube on 18 September.  This means that anyone with an Internet connection can watch the conference for free in real time.  In addition, each of the talks will be filmed and posted onto […]

Continue Reading 8

Rapid withdrawal and misprescribing of a benzodiazepine leads to £1.35m settlement for Luke Montagu, CEP co-founder

The UK Times Magazine today publishes a long article describing CEP founder Luke Montagu’s terrible experience with antidepressants and sleeping pills: When he was first prescribed these drugs at 19, Montagu was not depressed and had never been diagnosed with depression. He was a student at New York University, and had recently undergone a general […]

Continue Reading 38

CEP appointed as Secretariat for All Party Parliamentary Group for Prescribed Drug Dependence

The Council for Evidence-based Psychiatry has been appointed as the Secretariat for the All Party Parliamentary Group for Prescribed Drug Dependence (APPG for PDD). The APPG for Prescribed Drug Dependence (PDD) will address the growing problem of dependency on prescribed medication. Increasing numbers of prescriptions for addictive, psychoactive drugs are being given to both adults […]

Continue Reading 1

Powered by WordPress. Designed by Woo Themes